FAST NEWS: Livzon Pharma cancels repurchased H shares
The Latest: Livzon Pharmaceutical Group Inc. (1513.HK) announced on Friday that as of Jun. 27, 2024, it has repurchased a cumulative total of 2.78 million H shares, and all of which…
Recent Articles
RELATED ARTICLES
-
Hengrui Pharma accelerates bid for global brand status
600276.SHG -
Eshallgo looks skyward to cloud gaming to offset sputtering office business
EHGO.US
- Cash-strapped Mirxes looks for lifeline in blood-based cancer detection
-
Xuanzhu Biopharm set for spin-off in Hong Kong IPO
0460.HK
- Cloudbreak Pharma sets sights on Hong Kong IPO after license deal
-
BRIEF: Fosun pledges 27% of Fosun Pharma’s A-shares
2196.HK 600196.SHG
-
Qifu shares rally as credit tech takes off
3660.HK QFIN.US
